ATE501140T1 - (r)-4-(heteroaryl)phenylethylderivate und pharmazeutische zusammensetzungen damit - Google Patents

(r)-4-(heteroaryl)phenylethylderivate und pharmazeutische zusammensetzungen damit

Info

Publication number
ATE501140T1
ATE501140T1 AT08840589T AT08840589T ATE501140T1 AT E501140 T1 ATE501140 T1 AT E501140T1 AT 08840589 T AT08840589 T AT 08840589T AT 08840589 T AT08840589 T AT 08840589T AT E501140 T1 ATE501140 T1 AT E501140T1
Authority
AT
Austria
Prior art keywords
useful
treatment
heteroaryl
complement
fraction
Prior art date
Application number
AT08840589T
Other languages
English (en)
Inventor
Alessio Moriconi
Andrea Aramini
Original Assignee
Dompe Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Spa filed Critical Dompe Spa
Application granted granted Critical
Publication of ATE501140T1 publication Critical patent/ATE501140T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT08840589T 2007-10-18 2008-10-17 (r)-4-(heteroaryl)phenylethylderivate und pharmazeutische zusammensetzungen damit ATE501140T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07020396 2007-10-18
PCT/EP2008/064023 WO2009050258A1 (en) 2007-10-18 2008-10-17 (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
ATE501140T1 true ATE501140T1 (de) 2011-03-15

Family

ID=40325746

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08840589T ATE501140T1 (de) 2007-10-18 2008-10-17 (r)-4-(heteroaryl)phenylethylderivate und pharmazeutische zusammensetzungen damit

Country Status (19)

Country Link
US (1) US8133911B2 (de)
EP (1) EP2201006B1 (de)
JP (1) JP5374511B2 (de)
CN (1) CN101827841B (de)
AT (1) ATE501140T1 (de)
AU (1) AU2008313669B2 (de)
BR (1) BRPI0817824B8 (de)
CA (1) CA2702307C (de)
DE (1) DE602008005488D1 (de)
DK (1) DK2201006T3 (de)
ES (1) ES2361233T3 (de)
HK (1) HK1146723A1 (de)
HR (1) HRP20110406T1 (de)
IL (1) IL205029A (de)
PL (1) PL2201006T3 (de)
PT (1) PT2201006E (de)
RU (1) RU2475486C2 (de)
SI (1) SI2201006T1 (de)
WO (1) WO2009050258A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2166006A1 (de) * 2008-09-18 2010-03-24 Dompe' S.P.A. 2-Arylpropionsäuren und -Derivate und pharmazeutische Zusammensetzungen, die diese enthalten
EP3498269A1 (de) * 2017-12-12 2019-06-19 Dompé farmaceutici S.p.A. C5ar-inhibitoren zur verwendung bei der behandlung von durch chemotherapie ausgelöstem iatrogenem schmerz
CN115433143B (zh) * 2021-06-03 2023-10-13 中国科学院大连化学物理研究所 一种异噻唑啉酮类化合物的合成方法
EP4397306A1 (de) 2023-01-05 2024-07-10 Dompe' Farmaceutici S.P.A. C5ar1-inhibitoren zur verwendung bei der behandlung von augenschleimhaut-pemphigoid und/oder mundschleimhaut-pemphigoid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9710002A (pt) * 1996-06-27 1999-08-10 Janssen Pharmaceutica Nv N-[4-(heteroarilmetil)fenil]-heteroarilaminas
ITMI20012025A1 (it) * 2001-09-28 2003-03-28 Dompe Spa Sali di ammonio quaternari di omega-amminoalchilammidi di acidi r 2-aril-propionici e composizioni farmaceutiche che li contengono
RU2458051C2 (ru) * 2005-11-24 2012-08-10 ДОМПЕ ФА.Р.МА С.п.А. (r)-арилалкиламинопроизводные и содержащие их фармацевтические композиции

Also Published As

Publication number Publication date
WO2009050258A1 (en) 2009-04-23
DE602008005488D1 (de) 2011-04-21
JP5374511B2 (ja) 2013-12-25
BRPI0817824B1 (pt) 2018-12-26
HK1146723A1 (en) 2011-07-08
AU2008313669B2 (en) 2014-01-16
SI2201006T1 (sl) 2011-07-29
IL205029A0 (en) 2010-11-30
BRPI0817824B8 (pt) 2021-05-25
JP2011500643A (ja) 2011-01-06
BRPI0817824A2 (pt) 2015-03-31
RU2475486C2 (ru) 2013-02-20
US20100249198A1 (en) 2010-09-30
PT2201006E (pt) 2011-05-05
PL2201006T3 (pl) 2011-08-31
CN101827841A (zh) 2010-09-08
ES2361233T3 (es) 2011-06-15
CN101827841B (zh) 2012-11-28
CA2702307A1 (en) 2009-04-23
IL205029A (en) 2014-09-30
CA2702307C (en) 2016-04-05
AU2008313669A1 (en) 2009-04-23
EP2201006B1 (de) 2011-03-09
RU2010119705A (ru) 2011-11-27
DK2201006T3 (da) 2011-06-27
HRP20110406T1 (hr) 2011-06-30
US8133911B2 (en) 2012-03-13
EP2201006A1 (de) 2010-06-30

Similar Documents

Publication Publication Date Title
WO2007060215A3 (en) (r)-arylkylamino derivatives and pharmaceutical compositions containing them
DK1856031T3 (da) 2-arylpropionsyrederivater og farmaceutiske sammensætninger indeholdende disse
ATE501140T1 (de) (r)-4-(heteroaryl)phenylethylderivate und pharmazeutische zusammensetzungen damit
ATE463495T1 (de) Oxadiazolylpyrazolopyrimidine als mglur2- antagonisten
CL2012000311A1 (es) Compuestos derivados que contiene ciclos con 3 atomos de nitrogeno; utiles en el tratamiento de parasitosis en animales.
ATE512157T1 (de) Metallkomplexe
NO20083909L (no) Bisykliske benzimidazolforbindelser, og deres anvendelse som metabotropiske glutamatreseptorforsterkere
DE502006005130D1 (de) Metallkomplexe
UY30881A1 (es) Derivados de fenotiazina, procedimientos y su uso como productos farmacéuticos
TW200833641A (en) Polyacetylenic compounds
NO20061721L (no) Amidiner og derivater derav og farmasoytiske sammensetninger som inneholder disse
DE602006007210D1 (de) Metaboliten aus 2-arylpropionsäure-derivaten und pharmazeutische zusammensetzungen damit
Ivanets et al. Comparison of extraction ability of 18-term crown-ethers in relation to cesium
BR112017008533A2 (pt) melhorias em ou relacionadas com os compostos orgânicos
CA2897768C (en) Gem-difluorinated c-glycoside compounds as anti-cancer agents
TH90216B (th) ก้อนสบู่
TH90217B (th) ก้อนสบู่
TH90218B (th) ก้อนสบู่
TH76306A (th) อนุพันธ์เตตระอะซาเบนโซ [e] อะซูลีนและอะนาลอกของพวกมัน
TH100852B (th) สารประกอบเบนซาซีพีนและสารเตรียมทางเภสัชกรรม
TH106860B (th) สว่าน
TH114333B (th) ก้อนสบู่
TH87833B (th) อนุพันธ์ของเพอรราโซโลน
TH90215B (th) ก้อนสบู่
TH91733B (th) อิฐบล็อก

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
UEP Publication of translation of european patent specification

Ref document number: 2201006

Country of ref document: EP